Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? by Rosaria Vincenza Giglio BD, PhD, Emir M. Muzurović MD, PhD, Angelo Maria Patti MD, PhD, Peter P. Toth MD, PhD, Manyoo A. Agarwal MD, Wael Almahmeed MD, Aleksandra Klisic MD, PhD, Marcello Ciaccio MD, PhD, Manfredi Rizzo MD, PhD

Get full text